Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 330.14B | 365.91B | 270.97B | 280.04B | 328.31B | 245.87B |
Gross Profit | 69.72B | 76.56B | 57.48B | 47.58B | 58.26B | 36.75B |
EBITDA | 23.08B | 35.78B | 28.40B | 8.77B | 24.28B | 13.53B |
Net Income | 19.36B | 23.66B | 17.48B | 2.47B | 19.34B | 20.36B |
Balance Sheet | ||||||
Total Assets | 350.95B | 403.16B | 324.25B | 273.51B | 292.89B | 253.68B |
Cash, Cash Equivalents and Short-Term Investments | 99.58B | 101.77B | 107.83B | 67.78B | 86.17B | 95.53B |
Total Debt | 27.36B | 36.01B | 29.83B | 26.06B | 30.68B | 18.48B |
Total Liabilities | 173.12B | 213.95B | 159.99B | 129.58B | 155.46B | 129.67B |
Stockholders Equity | 177.24B | 188.74B | 164.00B | 143.66B | 137.21B | 123.69B |
Cash Flow | ||||||
Free Cash Flow | 16.93B | 32.00B | 35.03B | -10.19B | 2.62B | 18.85B |
Operating Cash Flow | 23.20B | 39.30B | 41.30B | -4.39B | 9.79B | 21.88B |
Investing Cash Flow | -12.17B | -35.39B | -35.17B | 15.55B | -45.01B | -17.68B |
Financing Cash Flow | -3.06B | -4.00B | -504.97M | -7.85B | 4.50B | 26.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $3.14T | 32.76 | 138.02% | 0.49% | 4.91% | -0.36% | |
75 Outperform | $189.36B | 44.31 | 14.98% | ― | 39.04% | 73.23% | |
74 Outperform | $153.25B | 20.44 | 14.32% | 0.50% | -5.46% | 14.01% | |
60 Neutral | $1.30B | ― | -15.80% | ― | -5.24% | -67.92% | |
55 Neutral | $3.35B | ― | -28.93% | ― | 17.34% | 34.72% | |
54 Neutral | $121.04M | ― | -83.57% | ― | -20.88% | 62.21% | |
50 Neutral | C$2.97B | 1.83 | -63.12% | 2.59% | 11.24% | -12.42% |